赛诺菲到2030年将于美国投资至少200亿美元，这将属于研发开支。

Core Insights - Sanofi plans to invest at least $20 billion in the United States by 2030, which will be allocated to research and development expenditures [1] Group 1 - The investment is aimed at enhancing the company's research capabilities and fostering innovation in the pharmaceutical sector [1] - This commitment reflects Sanofi's strategic focus on expanding its presence and impact in the U.S. market [1] - The investment is expected to contribute to the development of new therapies and treatments, aligning with industry trends towards increased R&D spending [1]